drugset / Trial / NCT04590937

A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body

NCT04590937

Phase 1 Completed 15 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

The main objective of this trial is to investigate the effect of BI 730357 under steady state conditions on the pharmacokinetics of digoxin, furosemide, metformin and rosuvastatin given as a cocktail (Reference, R: cocktail alone; Test T: cocktail given under steady state conditions of BI 730357).

Timeline

Start
2020-10-20
Primary completion
2021-01-11
Completion
2021-01-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 730357 Unknown
Subject Digoxin Other / unclassified
Subject Furosemide Other / unclassified Oral
Subject Metformin Small molecule Oral
Subject Rosuvastatin Small molecule

Indications

No indication recorded.